查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1619613

2024 年醫療保健領域生成式人工智慧全球市場報告

Generative AI In Medicine Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

醫療保健領域的生成人工智慧 (AI) 市場規模預計將在未來幾年呈指數級成長。 2028年，將以43.6%的複合年成長率成長至28.1億美元。預測期內的預期成長是由於高品質醫療資料可用性的增加、對預防性護理的日益關注、對高效臨床測試的需求不斷成長以及在需求不斷成長和使用不斷成長的推動下轉向人工智慧增強型病人參與工具。預計影響這段時期的主要趨勢包括技術進步、遠端醫療、個人化醫療、預測分析和穿戴式醫療技術。

醫療保健領域的生成人工智慧 (AI) 市場的成長預計將受到數位健康記錄的成長的推動。數位健康記錄或電子健康記錄(EHR) 是電子儲存的病患健康資訊的系統集合，有助於醫療機構之間的共用並提高患者照護的效率和品質。數位健康記錄的激增是由改善的患者照護、更有效率的醫療服務、監管支持和獎勵、技術進步以及增加的患者參與和賦權所推動的。醫療保健領域的人工智慧透過自動化記錄、組織資料、提供預測性見解和產生個人化摘要來增強數位健康記錄，從而提高準確性、可近性和整體患者照護。例如，2024 年 7 月，歐盟委員會報告稱，電子健康記錄的訪問率從 2023 年的 72% 增加到 2024 年的 79%。因此，數位醫療記錄的興起極大地推動了醫療保健領域的生成人工智慧市場的成長。

該市場的主要企業專注於開發創新技術，例如針對大腦健康和保健的人工智慧解決方案，以推進認知評估、改善患者照護並加強心理健康管理。針對大腦健康和保健的人工智慧解決方案是旨在評估、監測和改善認知功能和心理健康的先進技術。例如，2024 年 2 月，專門從事人工智慧數位治療方法的加拿大公司 DiagnaMed Holdings Corp. 宣布推出 CERVAI，這是第一個針對人類心理健康和保健的人工智慧解決方案。該解決方案利用先進的人工智慧來全面評估認知功能和大腦健康。它具有最先進的演算法，可以分析各種資料輸入，包括認知測試和大腦圖像，並提供有關您的心理健康狀況的準確見解。該工具提供個人化評估和可行的建議，促進認知問題的早期發現和量身定做的干涉措施。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球醫療保健領域生成式人工智慧的市場促進因素與限制
    • 市場促進因素
    • 市場限制因素
  • 2018-2023年全球醫療生成人工智慧市場規模表現與成長
  • 全球醫療保健領域生成式人工智慧的全球市場規模與成長預測，2023-2028 年、2033 年

第6章 市場細分

  • 2018-2023、2023-2028、2033 年醫療保健全球市場表現及預測（按組成部分）
  • 解決方案
  • 服務
  • 全球醫療保健生成人工智慧市場：按功能、效能和預測分類，2018-2023、2023-2028、2033
  • 虛擬護理助理
  • 機器人輔助AI手術
  • 最佳化管理流程
  • 醫學影像分析
  • 全球醫療保健生成人工智慧市場：按應用、效能和預測，2018-2023、2023-2028、2033
  • 醫學影像
  • 藥物發現
  • 醫學診斷
  • 患者資料分析
  • 其他
  • 全球醫療保健生成人工智慧市場：最終用戶的表現和預測，2018-2023、2023-2028、2033
  • 醫院和診所
  • 臨床研究
  • 醫療機構
  • 診斷中心
  • 其他

第 7 章 區域/國家分析

  • 全球醫療保健產生人工智慧市場，按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球醫療保健生成人工智慧市場，按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 醫療保健領域產生人工智慧市場的競爭格局
  • 醫療保健生成人工智慧市場公司概況
    • Microsoft Corporation
    • Intel Corporation
    • International Business Machines Corporation
    • NVIDIA Corporation
    • Philips Healthcare

第31章 其他重大及創新企業

  • Veeva Systems Inc.
  • Nuance Communications Inc.
  • Babylon Health Ltd.
  • Tempus Labs Inc.
  • DeepMind Technologies Limited
  • Owkin Inc.
  • Viz.ai Inc.
  • Recursion Pharmaceuticals Inc.
  • Caresyntax Inc.
  • Relay Therapeutics Inc.
  • Exscientia plc
  • Paige AI Inc.
  • BenevolentAI Limited
  • Atomwise Inc.
  • Healx Ltd.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20618

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative artificial intelligence (AI) in medicine market size has grown exponentially in recent years. It will grow from $0.46 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 43.5%. The growth observed in the historic period can be attributed to increased computational power and advancements in machine learning algorithms, the expansion of precision medicine, a rising demand for drug discovery, greater adoption of AI in diagnostic imaging, and increased investment in AI research and development.

The generative artificial intelligence (AI) in medicine market size is expected to see exponential growth in the next few years. It will grow to $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 43.6%. The anticipated growth during the forecast period is driven by the increasing availability of high-quality medical data, a heightened focus on preventive healthcare, the growing need for efficient clinical trials, rising demand for AI-enhanced patient engagement tools, and the expanding use of AI for drug repurposing. Key trends expected to shape this period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative AI in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative AI in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative AI in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Solutions; Service
  • 2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
  • 3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
  • 4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
  • Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Medicine Market Characteristics

3. Generative Artificial Intelligence (AI) In Medicine Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Medicine Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Generative Artificial Intelligence (AI) In Medicine Market Size and Growth

  • 5.1. Global Generative Artificial Intelligence (AI) In Medicine Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Generative Artificial Intelligence (AI) In Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Generative Artificial Intelligence (AI) In Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Generative Artificial Intelligence (AI) In Medicine Market Segmentation

  • 6.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Solutions
  • Service
  • 6.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Function, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Virtual Nursing Assistants
  • Robot-Assisted AI Surgery
  • Administrative Process Optimization
  • Medical Imaging Analysis
  • 6.3. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medical Imaging
  • Drug Discovery
  • Medical Diagnosis
  • Patient Data Analysis
  • Other Applications
  • 6.4. Global Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Clinical Research
  • Healthcare Organizations
  • Diagnostic Centers
  • Other End-Users

7. Generative Artificial Intelligence (AI) In Medicine Market Regional And Country Analysis

  • 7.1. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Generative Artificial Intelligence (AI) In Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market

  • 8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Generative Artificial Intelligence (AI) In Medicine Market

  • 9.1. China Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 9.2. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Generative Artificial Intelligence (AI) In Medicine Market

  • 10.1. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Medicine Market

  • 11.1. Japan Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 11.2. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Medicine Market

  • 12.1. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Medicine Market

  • 13.1. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Medicine Market

  • 14.1. South Korea Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 14.2. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Medicine Market

  • 15.1. Western Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 15.2. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Medicine Market

  • 16.1. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Medicine Market

  • 17.1. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Generative Artificial Intelligence (AI) In Medicine Market

  • 18.1. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Medicine Market

  • 19.1. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Medicine Market

  • 20.1. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market

  • 21.1. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 21.2. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Medicine Market

  • 22.1. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Medicine Market

  • 23.1. North America Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 23.2. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Medicine Market

  • 24.1. USA Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 24.2. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Medicine Market

  • 25.1. Canada Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 25.2. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Medicine Market

  • 26.1. South America Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 26.2. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Medicine Market

  • 27.1. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Medicine Market

  • 28.1. Middle East Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 28.2. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Medicine Market

  • 29.1. Africa Generative Artificial Intelligence (AI) In Medicine Market Overview
  • 29.2. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Generative Artificial Intelligence (AI) In Medicine Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Generative Artificial Intelligence (AI) In Medicine Market Competitive Landscape
  • 30.2. Generative Artificial Intelligence (AI) In Medicine Market Company Profiles
    • 30.2.1. Microsoft Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Intel Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. International Business Machines Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. NVIDIA Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Philips Healthcare
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Generative Artificial Intelligence (AI) In Medicine Market Other Major And Innovative Companies

  • 31.1. Veeva Systems Inc.
  • 31.2. Nuance Communications Inc.
  • 31.3. Babylon Health Ltd.
  • 31.4. Tempus Labs Inc.
  • 31.5. DeepMind Technologies Limited
  • 31.6. Owkin Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. Recursion Pharmaceuticals Inc.
  • 31.9. Caresyntax Inc.
  • 31.10. Relay Therapeutics Inc.
  • 31.11. Exscientia plc
  • 31.12. Paige AI Inc.
  • 31.13. BenevolentAI Limited
  • 31.14. Atomwise Inc.
  • 31.15. Healx Ltd.

32. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Benchmarking

33. Global Generative Artificial Intelligence (AI) In Medicine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Medicine Market

35. Generative Artificial Intelligence (AI) In Medicine Market Future Outlook and Potential Analysis

  • 35.1 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Generative Artificial Intelligence (AI) In Medicine Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer